Your browser doesn't support javascript.
loading
Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France.
Roland, Noémie; Drouin, Jérôme; Desplas, David; Duranteau, Lise; Cuenot, François; Dray-Spira, Rosemary; Weill, Alain; Zureik, Mahmoud.
Afiliación
  • Roland N; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France; University of Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective Evasion and Pharmacoepidemiology, CESP (Center for
  • Drouin J; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France.
  • Desplas D; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France.
  • Duranteau L; Adolescent and Young Adult Gynaecology Unit and Reference Center for Rare, Diseases of Genital Development, AP.HP University of Paris Saclay, Bicêtre Hospital, Le Kremlin Bicêtre, France.
  • Cuenot F; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France.
  • Dray-Spira R; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France.
  • Weill A; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France.
  • Zureik M; EPI-PHARE, epidemiology of health products (French National Agency for Medicines and Health Products Safety, and French National Health Insurance), Saint-Denis Cedex, France; University of Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective Evasion and Pharmacoepidemiology, CESP (Center for
Contraception ; 108: 50-55, 2022 04.
Article en En | MEDLINE | ID: mdl-34971603
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticonceptivos Femeninos / Anticoncepción Postcoital / COVID-19 Límite: Adolescent / Adult / Female / Humans / Infant / Pregnancy Idioma: En Revista: Contraception Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticonceptivos Femeninos / Anticoncepción Postcoital / COVID-19 Límite: Adolescent / Adult / Female / Humans / Infant / Pregnancy Idioma: En Revista: Contraception Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos